SOUTH SAN FRANCISCO, CA--(Marketwire - Nov 1, 2012) - In the news release “Onyx Pharmaceuticals Reports Third Quarter 2012 Financial Results,” issued earlier today by Onyx Pharmaceuticals ( NASDAQ : ONXX ), we are advised by the company that in the fourth financial table, “RECONCILIATION OF GAAP TO NON-GAAP NET INCOME (LOSS)”, the first and third figures in column one should read "$(51,834)” rather than "$51,834" and the final two figures in column one should read "$(0.79)” rather than "$0.79" as originally issued. Complete corrected text follows
